Dobutamine
-
Subject Areas on Research
- A bridge for the 21st century in heart transplantation?
- Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
- An experimental model of chronic myocardial hibernation.
- Analysis of cardiac arrhythmias during dobutamine pharmacologic stress testing in nuclear cardiology as related to the presence or absence of baseline arrhythmias.
- Beta(2)-adrenergic and several other G protein-coupled receptors in human atrial membranes activate both G(s) and G(i).
- Cardio-protective effects of carnitine in streptozotocin-induced diabetic rats.
- Cardiovascular MRI for detection of myocardial viability and ischaemia.
- Changes in regional myocardial function after coronary artery bypass graft surgery are predicted by intraoperative low-dose dobutamine echocardiography.
- Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
- Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction.
- Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
- Defining end systole for end-systolic pressure-volume ratio.
- Dobutamine stress echocardiography for orthotopic liver transplant evaluation.
- Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation.
- Does hypotension during dobutamine stress echocardiography correlate with anatomic or functional cardiac impairment?
- Dopamine and dobutamine in septic shock. A comparison.
- Echocardiography for the assessment of myocardial viability.
- Effect of dobutamine stress echocardiography on mitral regurgitation.
- Enhanced contractility and decreased beta-adrenergic receptor kinase-1 in mice lacking endogenous norepinephrine and epinephrine.
- Enhancement of the force-frequency effect on myocardial contractility by adrenergic stimulation in conscious dogs.
- Evaluation of ischemic heart disease.
- Evaluation of myocardial viability by MRI.
- Force-frequency relations in the failing rabbit heart and responses to adrenergic stimulation.
- GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
- Heart size-independent analysis of myocardial function in murine pressure overload hypertrophy.
- Hypotension during dobutamine stress echocardiography: is it related to dynamic intraventricular obstruction?
- Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables.
- Is there a long-term predictive value of intraoperative low-dose dobutamine echocardiography in patients who have coronary artery bypass graft surgery with cardiopulmonary bypass?
- Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure.
- Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy.
- Micro-CT imaging assessment of dobutamine-induced cardiac stress in rats.
- Myocardial contractile reserve and perfusion defect severity with rest and stress dobutamine (99m)Tc-sestamibi SPECT in canine stunning and subendocardial infarction.
- Noninvasive, quantitative assessment of left ventricular function in ischemic cardiomyopathy.
- Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
- Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol.
- Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning.
- Principal strain orientation in the normal human left ventricle.
- Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
- Protein kinase A and G protein-coupled receptor kinase phosphorylation mediates beta-1 adrenergic receptor endocytosis through different pathways.
- Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
- Reduced force production during low blood flow to the heart correlates with altered troponin I phosphorylation.
- Right ventricular injury in young swine: effects of catecholamines on right ventricular function and pulmonary vascular mechanics.
- Selectivity of dobutamine for adrenergic receptor subtypes: in vitro analysis by radioligand binding.
- Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure.
- Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure.
- Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols.
- Stress echocardiography, contrast echocardiography, and tissue characterization: applications for the future.
- Systolic contraction within aneurysmal rabbit myocardium following transplantation of autologous skeletal myoblasts.
- The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
- The influence of angiographically demonstrated coronary collaterals on the results of stress echocardiography.
- Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF.
- Transthoracic echocardiography in models of cardiac disease in the mouse.
- Usefulness of dobutamine echocardiography for detecting restenosis after percutaneous transluminal coronary angioplasty.
- Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization.
- Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?
-
Keywords of People
- O'Connor, Christopher Michael, Richard Sean Stack, M.D. / Guidant Foundation Professor of Cardiology, Medicine, Clinical Pharmacology